Market Size of Animal Model Industry
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 8.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Animal Model Market Analysis
The animal model market is expected to register a CAGR of 8.6% over the forecast period.
The COVID-19 pandemic posed several challenges for the animal model market. For instance, an article published by NCBI, in July 2022, reported that, since the COVID-19 outbreak, animal models played a crucial role in aiding the rapid development of vaccines/drugs for the prevention and treatment of COVID-19, as well as understanding the pathogenesis of SARS-CoV-2 infection and immune responses of hosts, which led to increasing demand for animal models. However, due to the emergence of new SARS-CoV-2 strains and other new diseases, along with the continuous development of new drug molecules, the demand for animal models may continue to increase over the forecast period.
The rising usage of animal models in virology and infectious diseases, increased adoption of CRISPR technology, and an increasing number of R&D activities are driving the market's growth. The increasing number of infectious diseases leading to the death of billions of people worldwide have accelerated the development of vaccines, further increasing the use of animal models for drug testing studies. For instance, in February 2022, the WHO reported that 47,689 preclinical trial studies were registered in 2021. Thus, the increasing number of preclinical studies is also boosting the demand for animal models to conduct research, thereby driving the growth of the market.
The CRISPR-Cas system is used for target identification and validation, faster generation of safety models, and the development of cell-based therapies such as CAR-T cells for immunotherapy and CCR5 knockout cells for HIV treatment. Thus, the demand for animal models for production and quality control is increasing, thereby driving the market. For instance, an article published in the Molecular Neurobiology journal, in February 2022, reported that CRISPR/Cas9-based genome editing is becoming one of the most promising tools for treating human genetic diseases, including cardiovascular diseases, neuro-disorders, cancers, leading to the rising demand for animal genetic models for studying and treating human genetic disorders, particularly diseases associated with point mutations.
The development of CRISPR/Cas-9 technology is fueling the growth of the market. For instance, in September 2021, researchers from the Washington University School of Medicine used a mouse model to study the behavior of CRISPR-engineered cells for the treatment of rheumatoid arthritis. Hence, the increasing R&D in animal studies may further boost the growth of animal model market in the future.
However, regulations for the ethical use of animals may slow down the growth of the market over the forecast period.
